Clinical report on external irradiation combined with californium-252 neutron intraluminal brachytherapy for cervical carcinoma treatment

Tumori

Volumn 93, Issue 6, 2007, Pages 636-640

  Zhao, Huanyu ^a   Wang, Keming ^b   Sun, Jian ^b   Geng, Xin ^a   Zhang, Weiming ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Brachytherapy; Californium 252 neutron; Cervical carcinoma; Radiotherapy

Indexed keywords

CALIFORNIUM 252;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; RADIATION DOSE; SHORT COURSE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TUMOR CELL; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA;

EID: 38549100103     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160709300624     Document Type: Article

References (14)

1. Maruyama Y, Beach JL, Feola J: Scheduling of hypoxic tumor therapy using neutron brachytherapy. Radiology, 137: 775-778, 1980.
2. Feola JM, Nava A, Maruyama Y: Biological effects of Cf-252 neutrons at low dose rate. Int J Radiat Biol, 41: 33-46, 1980.
3. Martin RC, Knauer JB, Balo PA: Production, distribution and applications of californium-252 neutron sources. Appl Radiat Isot, 53: 785-792, 2000.
4. Maruyama Y, van Nagell JR, Yoneda J, Donaldson ES, Gallion HH, Powell D, Kryscio RJ: A review of californium-252 neutron brachytherapy for cervical cancer. Cancer, 68: 1189-1197, 1991.
5. Maruyama Y, Feola JM, Wierzbicki J: Study of biological effects of varying mixtures of Cf-252 and P radiation on the acute radiation syndromes: relevance to clinical radiotherapy of radioresistant cancer. Int J Radiat Oncol Biol Phys, 27: 907-914, 1993.
6. Maruyama Y, Van Nagell JR, Yoneda J, Gallion HH, Depriest P, Feola JM, Wierzbicki J: Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial. Am J Clin Oncol, 16: 168-174, 1993.
7. Maruyama Y, Mesina J, Yudelev M, Wierzbicki J, Deppe G, Porter AT: New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future. Strahlenther Oncol, 170: 253-263, 1994.
8. Luo G, Zheng CW, Shan JL, Liu J, Shen YX: The preliminary report of cervical cancer treated with californium 252 neutron afterloading intracavitary radiotherapy. Chin J Obstet Gynecol, 36: 742-744, 2001.
9. Wang YW, Li AL, Yao X, Zhang LS: Intracavitary brachytherapy and external beam radiotherapy for 367 cases of cervical carcinoma. J Prac Diagn Ther, 17: 302-303, 2003.
10. 252Cf neutron intraluminal brachytherapy for treatment of cervical carcinoma and corpus carcinoma. Chin J Radiat Oncol, 6: 145-146, 1997.
11. 192Ir afterloading intracavitary brachytherapy and external beam radiotherapy for carcinoma of uterine cervix. Chin J Radiat Oncol, 11: 235-236, 2002.
12. 252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma. Strahlenther Onkol, 179: 377-384, 2003.
13. Zeng DH, Liang YX, Tian Q: Intracavitary brachytherapy combined with external beam radiotherapy for 183 cases of cervical carcinoma. Journal of Youjiang Nationalities Medical College, 2: 208-209, 2005.
14. Wang P, Lu P: COX model analysis for prognostic factors of cervical carcinoma. Foreign Medical Science (Section of Maternal and Child Health), 13: 273-275, 2002.